British journal of cancer · 2026
Non-invasive biomarkers for early oral cancer detection through multiomics approach.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Verma Tarun Prakash, Singh Siddharth, Meloth Sreenath, Chaudhary Neha, Nad Paniki, Chaudhary Anjali, Chandramohanadas Rajesh, Agrawal Deepak, Jha Hem Chandra
Аннотация
BACKGROUND: Non-invasive biomarker-based approaches are urgently needed to support early identification and monitoring of Oral squamous cell carcinoma (OSCC) and its precursor, oral submucous fibrosis (OSMF).
METHODS: We employed combined metabolomic and proteomic analyses to profile saliva and lesion surface swabs from clinically diagnosed OSCC (n = 15), OSMF (n = 20), and healthy controls (n = 27). Polar and nonpolar metabolites were extracted separately from saliva, while proteins were isolated from exfoliated mucosal epithelial cells. Differential expression, pathway enrichment, and biomarker classification were performed across four comparisons: OSCC vs non-OSCC (controls + OSMF), OSCC vs OSMF, OSMF vs control, and OSCC vs control.
RESULTS: Distinct molecular changes were observed across the health-to-cancer spectrum. Top discriminatory salivary metabolites included linoelaidic acid, gamma-glutamylcysteine, and 3-hydroxybutyryl-CoA, implicating dysregulated linoleic acid metabolism, redox imbalance, and fatty acid β-oxidation in pathogenesis. Proteomic data revealed significant upregulation of histone variants, cytoskeletal keratins, and BPI-fold-containing proteins in OSCC, reflecting chromatin remodelling and epithelial-mesenchymal transition. Multivariate biomarker panels achieved high accuracy (AUC ≥ 0.96) for classifying OSMF from OSCC.
CONCLUSION: Our combined metabolomic and proteomic profiling revealed non-invasive molecular signatures for early detection and monitoring of OSCC and OSMF.
METHODS: We employed combined metabolomic and proteomic analyses to profile saliva and lesion surface swabs from clinically diagnosed OSCC (n = 15), OSMF (n = 20), and healthy controls (n = 27). Polar and nonpolar metabolites were extracted separately from saliva, while proteins were isolated from exfoliated mucosal epithelial cells. Differential expression, pathway enrichment, and biomarker classification were performed across four comparisons: OSCC vs non-OSCC (controls + OSMF), OSCC vs OSMF, OSMF vs control, and OSCC vs control.
RESULTS: Distinct molecular changes were observed across the health-to-cancer spectrum. Top discriminatory salivary metabolites included linoelaidic acid, gamma-glutamylcysteine, and 3-hydroxybutyryl-CoA, implicating dysregulated linoleic acid metabolism, redox imbalance, and fatty acid β-oxidation in pathogenesis. Proteomic data revealed significant upregulation of histone variants, cytoskeletal keratins, and BPI-fold-containing proteins in OSCC, reflecting chromatin remodelling and epithelial-mesenchymal transition. Multivariate biomarker panels achieved high accuracy (AUC ≥ 0.96) for classifying OSMF from OSCC.
CONCLUSION: Our combined metabolomic and proteomic profiling revealed non-invasive molecular signatures for early detection and monitoring of OSCC and OSMF.